These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2785102)

  • 21. A review of the pharmacokinetics and pharmacodynamics of aztreonam.
    Ramsey C; MacGowan AP
    J Antimicrob Chemother; 2016 Oct; 71(10):2704-12. PubMed ID: 27334663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery and development of the monobactams.
    Sykes RB; Bonner DP
    Rev Infect Dis; 1985; 7 Suppl 4():S579-93. PubMed ID: 3909315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimization of novel monobactams with activity against carbapenem-resistant Enterobacteriaceae - Identification of LYS228.
    Reck F; Bermingham A; Blais J; Capka V; Cariaga T; Casarez A; Colvin R; Dean CR; Fekete A; Gong W; Growcott E; Guo H; Jones AK; Li C; Li F; Lin X; Lindvall M; Lopez S; McKenney D; Metzger L; Moser HE; Prathapam R; Rasper D; Rudewicz P; Sethuraman V; Shen X; Shaul J; Simmons RL; Tashiro K; Tang D; Tjandra M; Turner N; Uehara T; Vitt C; Whitebread S; Yifru A; Zang X; Zhu Q
    Bioorg Med Chem Lett; 2018 Feb; 28(4):748-755. PubMed ID: 29336873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emergence of resistance to beta-lactam agents in enterobacteriaceae species with group I beta-lactamases in Spain.
    Colom K; Fernández-Aranguiz A; Alonso R; Suinaga E; Cisterna R
    Microb Drug Resist; 1996; 2(3):353-9. PubMed ID: 9158795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of BAL30376 (monobactam BAL19764 + BAL29880 + clavulanate) versus Gram-negative bacteria with characterized resistance mechanisms.
    Livermore DM; Mushtaq S; Warner M
    J Antimicrob Chemother; 2010 Nov; 65(11):2382-95. PubMed ID: 20846937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of beta-lactamase induction and stable derepression in gram-negative rods.
    Livermore DM
    Eur J Clin Microbiol; 1987 Aug; 6(4):439-45. PubMed ID: 3311738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo properties of BAL30376, a β-lactam and dual beta-lactamase inhibitor combination with enhanced activity against Gram-negative Bacilli that express multiple β-lactamases.
    Page MG; Dantier C; Desarbre E; Gaucher B; Gebhardt K; Schmitt-Hoffmann A
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1510-9. PubMed ID: 21245441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of cefpirome against beta-lactamase-inducible and stably derepressed Enterobacteriaceae.
    Binfiglio G; Stefani S; Nicoletti G
    Chemotherapy; 1994; 40(5):311-6. PubMed ID: 7956454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction potency of various beta-lactam derivatives in gram-negative rods.
    Cullmann W; Dick W
    Chemotherapy; 1989; 35(1):43-53. PubMed ID: 2785904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increasing extended-spectrum beta-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia/Pacific region: data from the Smart Study 2002-2006.
    Ko WC; Hsueh PR
    J Infect; 2009 Aug; 59(2):95-103. PubMed ID: 19564044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Restoration of antibacterial activity of beta-lactams by epigallocatechin gallate against beta-lactamase-producing species depending on location of beta-lactamase.
    Zhao WH; Asano N; Hu ZQ; Shimamura T
    J Pharm Pharmacol; 2003 Jun; 55(6):735-40. PubMed ID: 12841932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carumonam's in-vitro activity against gram-negative bacteria and its stability to their beta-lactamases.
    Raimondi A; Mattina R; Cocuzza CE
    Chemioterapia; 1988 Feb; 7(1):3-9. PubMed ID: 3288365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High activity of meropenem against Gram-negative bacteria from a paediatric Intensive Care Unit, 2001-2005.
    Patzer JA; Dzierzanowska D; Pawińska A; Turner PJ
    Int J Antimicrob Agents; 2007 Mar; 29(3):285-8. PubMed ID: 17257814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Correlation between beta-lactamase production and the test of in vitro enzyme induction in 70 strains of gram-negative bacteria isolated in a hospital environment].
    Bovelacci A; Foà-Tomasi L; Ramacciotti PG
    Ann Sclavo; 1982; 24(6):586-95. PubMed ID: 6821296
    [No Abstract]   [Full Text] [Related]  

  • 36. The in vitro activity of tigemonam: a comparison with other antimicrobial agents.
    Andrews JM; Wise R
    J Chemother; 1989 May; 1 Suppl 2():5-12. PubMed ID: 2509645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Beta-lactamases of Gram negative bacteria: never-ending clockwork!].
    Philippon A; Arlet G
    Ann Biol Clin (Paris); 2006; 64(1):37-51. PubMed ID: 16420989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo evaluation of tigemonam, a novel oral monobactam.
    Clark JM; Olsen SJ; Weinberg DS; Dalvi M; Whitney RR; Bonner DP; Sykes RB
    Antimicrob Agents Chemother; 1987 Feb; 31(2):226-9. PubMed ID: 3551830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of the presence of different broad-spectrum beta-lactamases among clinical isolates of Enterobacteriacae.
    Nagy E; Pragai Z; Kóczián Z; Hajdú E; Fodor E
    Acta Microbiol Immunol Hung; 1998; 45(3-4):433-46. PubMed ID: 9873949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of beta-lactamases in gram-negative bacilli.
    Wise R; Ashby JP; Piddock LJ
    J Antimicrob Chemother; 1987 Nov; 20(5):767-8. PubMed ID: 3501423
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.